Laboratoire d'Hématologie Moléculaire-Etablissement Français du Sang Alpes Méditerranée, UMR 7268-Aix-Marseille Université, Marseille, France.
Transfusion. 2013 May;53(5):955-61. doi: 10.1111/j.1537-2995.2012.03860.x. Epub 2012 Sep 7.
The RH blood group system has many RHCE variant alleles that have arisen through gene conversion or nucleotide changes. Two probands, with red blood cells (RBCs) that were D+C+E-c+(w) e+ were sent to our laboratories to resolve the weak c expression.
Hemagglutination tests were performed by automated and manual procedures. Genomic DNA analysis was performed by sequencing of Exons 1 to 10 of RHCE and RHD.
The probands' RBCs did not react with standard monoclonal anti-E reagents from Bio-Rad, Diagast, DiaMed, Immucor, Ortho, and Quotient. The RBCs reacted variably with anti-c reagents from Diagast, DiaMed, Immucor, or Ortho and did not react with the Quotient anti-c reagent. Surprisingly, sequencing results of RHCE showed the presence of C/G at Position 676 (E/e polymorphism) and the association of the E polymorphism with a 734T>C transition in Exon 5 of the RHCE, encoding a Leu245Pro amino acid substitution in the mature RhcE polypeptide. Replacement of leucine 245 by proline in the eighth transmembrane domain of the RhcE protein may have a steric effect on the protein such that most anti-E reagents do not bind and the interaction between anti-c and c antigen is also affected.
We report a novel RHCEcE allele, RHCEcE734C, which was assigned the provisional ISBT allele name RHCEcE.14 or RHCE03.14. It was found in two probands whose RBCs had weakened c expression and typed E- with conventional anti-E reagents. These data, once again, highlight the fact that the genotype does not always reflect the phenotype.
RH 血型系统中有许多 RHCE 变异等位基因,这些等位基因是通过基因转换或核苷酸变化产生的。两个红细胞(RBC)表现为 D+C+E-c+(w)e+的先证者被送到我们的实验室,以解决 c 抗原表达减弱的问题。
通过自动和手动程序进行血凝试验。通过对 RHCE 和 RHD 的外显子 1 到 10 进行测序来进行基因组 DNA 分析。
先证者的 RBC 与来自 Bio-Rad、Diagast、DiaMed、Immucor、Ortho 和 Quotient 的标准单克隆抗-E 试剂均无反应。RBC 与 Diagast、DiaMed、Immucor 或 Ortho 的抗-c 试剂反应程度不同,与 Quotient 的抗-c 试剂无反应。令人惊讶的是,RHCE 的测序结果显示,676 位存在 C/G(E/e 多态性),并且 E 多态性与 RHCE 外显子 5 中的 734T>C 转换相关,该转换编码 RhcE 成熟多肽中的亮氨酸 245 被脯氨酸取代。RhcE 蛋白第八个跨膜结构域中亮氨酸 245 被脯氨酸取代可能会对该蛋白产生空间位阻,导致大多数抗-E 试剂无法结合,抗-c 与 c 抗原的相互作用也受到影响。
我们报告了一种新的 RHCEcE 等位基因,RHCEcE734C,其被赋予暂定的 ISBT 等位基因名称 RHCEcE.14 或 RHCE03.14。它在两个 RBC 表达减弱的 c 抗原,且常规抗-E 试剂表现为 E-的先证者中被发现。这些数据再次强调了基因型并不总是反映表型的事实。